Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Recruiting

EvolocumabEffect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Sponsor:

Unity Health Toronto

Code:

NCT03900026

Conditions

Coronary Artery Bypass Graft Surgery

Atherosclerosis

Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evolocumab

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Unity Health Toronto on 2020-07-13.